The only approved gene therapy for RP today targets a single gene RPE65, which accounts for just 1% to 2% of the total RP patient population. We believe OCU400 has significantly wider commercial ...
Tom's Hardware ☛ Drones attack several proprietary trap AWS Middle East region data centers amid Iran war, leading to outages ...